BioAge Labs
BIOA
94 hedge funds and large institutions have $125M invested in BioAge Labs in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 3 closing their positions.
367% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 3
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
46% more capital invested
Capital invested by funds: $85.6M → $125M (+$39.4M)
13% more funds holding
Funds holding: 83 → 94 (+11)
1.51% more ownership
Funds ownership: 57.79% → 59.3% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
96% less call options, than puts
Call options by funds: $70K | Put options by funds: $1.75M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.27M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
+$566K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$512K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$439K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$333K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$826K |
| 2 |
O
OrbiMed
New York
|
-$614K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$283K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$267K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$246K |
BIOA Hedge Fund Activity: Q3 2025 in Review
94 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q3 2025, worth a combined $125M — up 46% from $85.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BIOA positions and 3 closed out — a net gain of 11 holders — while 32 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.27M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $826K sold.
- 94 institutional investors held BioAge Labs (BIOA) as of Q3 2025, up from 83 in Q2 2025.
- Funds reported $125M of BioAge Labs stock for Q3 2025, up 46% quarter-over-quarter.
- 14 funds opened new BioAge Labs positions in Q3 2025 and 3 closed out, a net change of +11 holders.
- The largest BioAge Labs buyer in Q3 2025 was Millennium Management, an estimated $1.27M added.
- The largest BioAge Labs seller in Q3 2025 was Cantor Fitzgerald, an estimated $826K sold.
Based on aggregated 13F filings for Q3 2025.